4.7 Article

Non-Nucleoside Inhibitors of BasE, an Adenylating Enzyme in the Siderophore Biosynthetic Pathway of the Opportunistic Pathogen Acinetobacter baumannii

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 56, Issue 6, Pages 2385-2405

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm301709s

Keywords

-

Funding

  1. National Institutes of Health [AI070219, GM-068440]
  2. Intramural Research Program of the NIAID in the National Institutes of Health

Ask authors/readers for more resources

Siderophores are small-molecule iron chelators produced by bacteria and other microorganisms for survival under iron limiting conditions such as found in a mammalian host. Siderophore biosynthesis is essential for the virulence of many important Gram-negative pathogens including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli. We performed high-throughput screening against BasE, which is involved in siderophore biosynthesis in A. baumannii, and identified 6-phenyl-1-(pyridin-4-ylmethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid 15. Herein we report the synthesis, biochemical, and microbiological evaluation of a systematic series of analogues of the HTS hit 15. Analogue 67 is the most potent analogue with a K-D of 2 nM against BasE. Structural characterization of the inhibitors with BasE reveals that they bind in a unique orientation in the active site, occupying all three substrate binding sites, and thus can be considered as multisubstrate inhibitors. These results provide a foundation for future studies aimed at increasing both enzyme potency and antibacterial activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The Siderophore Synthetase IucA of the Aerobactin Biosynthetic Pathway Uses an Ordered Mechanism

Lisa S. Mydy, Daniel C. Bailey, Ketan D. Patel, Matthew R. Rice, Andrew M. Gulick

BIOCHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Design, Synthesis, and Biophysical Evaluation of Mechanism-Based Probes for Condensation Domains of Nonribosomal Peptide Synthetases

Ce Shi, Bradley R. Miller, Evan M. Alexander, Andrew M. Gulick, Courtney C. Aldrich

ACS CHEMICAL BIOLOGY (2020)

Article Chemistry, Medicinal

Biosynthesis, Mechanism of Action, and Inhibition of the Enterotoxin Tilimycin Produced by the Opportunistic Pathogen Klebsiella oxytoca

Evan M. Alexander, Dale F. Kreitler, Valeria Guidolin, Alexander K. Hurben, Eric Drake, Peter W. Villalta, Silvia Balbo, Andrew M. Gulick, Courtney C. Aldrich

ACS INFECTIOUS DISEASES (2020)

Article Immunology

MAIT cell-directed therapy ofMycobacterium tuberculosisinfection

Shunsuke Sakai, Keith D. Kauffman, Sangmi Oh, Christine E. Nelson, Clifton E. Barry, Daniel L. Barber

Summary: The study found that MAIT cells mount minimal responses following Mtb infection, but MAIT cell expansion during chronic infection can reduce bacterial loads. The 5-OP-RU vaccination failed to protect against Mtb challenge, but MAIT cells play a role in delaying T cell priming.

MUCOSAL IMMUNOLOGY (2021)

Review Parasitology

p67: a cryptic lysosomal hydrolase in Trypanosoma brucei?

Carolina M. Koeller, Terry K. Smith, Andrew M. Gulick, James D. Bangs

Summary: p67 is a type I transmembrane glycoprotein located in the terminal lysosome of African trypanosomes. Knockdown of p67 is lethal, resulting in an enlarged lysosome. Orthologues of p67 have been identified in Dictyostelium and mammals, and are believed to possess phospholipase B-like activity.

PARASITOLOGY (2021)

Article Chemistry, Physical

Modeling the Role of a Flexible Loop and Active Site Side Chains in Hydride Transfer Catalyzed by Glycerol-3-phosphate Dehydrogenase

Anil R. Mhashal, Adrian Romero-Rivera, Lisa S. Mydy, Judith R. Cristobal, Andrew M. Gulick, John P. Richard, Shina C. L. Kamerlin

ACS CATALYSIS (2020)

Review Biochemical Research Methods

Siderophore natural products as pharmaceutical agents

Girish Swayambhu, Michael Bruno, Andrew M. Gulick, Blaine A. Pfeifer

Summary: Siderophore natural products are characterized by their ability to tightly chelate metals, with origins often found in pathogenic microbes. Despite the traditional association with pathogenicity, the evolutionarily-optimized binding abilities of siderophores suggest potential for redirection towards alternative beneficial applications.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Editorial Material Biochemistry & Molecular Biology

Anti-Zika candidates from a marine fungus with a remarkable biosynthetic repertoire

Ketan D. Patel, Andrew M. Gulick

Summary: The study of natural products presents opportunities for discovering novel biologically active molecules and biosynthetic pathways. For example, research on cyclic depsipeptides biosynthesized by marine fungi can lead to insights into their synthesis and antiviral properties, such as inhibiting Zika virus replication.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Editorial Material Biochemistry & Molecular Biology

The Tuberculosis Drug Accelerator at year 10: what have we learned?

Bree B. Aldridge, David Barros-Aguirre, Clifton E. Barry, Robert H. Bates, Steven J. Berthel, Helena I. Boshoff, Kelly Chibale, Xin-Jie Chu, Christopher B. Cooper, Veronique Dartois, Ken Duncan, Nader Fotouhi, Fabian Gusovsky, Philip A. Hipskind, Dale J. Kempf, Joel Lelievre, Anne J. Lenaerts, Case W. McNamara, Valerie Mizrahi, Carl Nathan, David B. Olsen, Tanya Parish, H. Michael Petrassi, Alexander Pym, Kyu Y. Rhee, Gregory T. Robertson, Jeremy Michael Rock, Eric J. Rubin, Betsy Russell, David G. Russell, James C. Sacchettini, Dirk Schnappinger, Michael Schrimpf, Anna M. Upton, Peter Warner, Paul Graham Wyatt, Ying Yuan

Summary: The Tuberculosis Drug Accelerator has successfully facilitated collaboration in tuberculosis drug discovery, breaking down barriers among competing labs and institutions. The achievements, advantages, and limitations of the consortium suggest that similar models could be applied to research on other diseases.

NATURE MEDICINE (2021)

Editorial Material Immunology

Signature required: The transcriptional response to tuberculosis

Clifton E. Barry, Katrin D. Mayer-Barber

Summary: Despite the majority of humans infected with Mycobacterium tuberculosis not showing clinical symptoms, predicting those who will remains challenging. Recent studies have revealed patterns and pathways that determine who is at highest risk for progression.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Editorial Material Critical Care Medicine

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel

Christoph Lange, Clifton E. Barry, C. Robert Horsburgh

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Biology

Phylogenomic analysis of the diversity of graspetides and proteins involved in their biosynthesis

Kira S. Makarova, Brittney Blackburne, Yuri Wolf, Anastasia Nikolskaya, Svetlana Karamycheva, Marlene Espinoza, Clifton E. Barry, Carole A. Bewley, Eugene Koonin

Summary: This study comprehensively analyzed BGCs encoding graspetides and reported several novel graspetide groups and associated proteins involved in their biosynthesis and expression. The results revealed previously unsuspected diversity in graspetide sequences and expanded the known diversity of RiPPs. The findings of this study are important for advancing approaches to identify RiPPs.

BIOLOGY DIRECT (2022)

Article Biochemistry & Molecular Biology

An acyl-adenylate mimic reveals the structural basis for substrate recognition by the iterative siderophore synthetase DesD

Jinping Yang, Victoria S. Banas, Ketan D. Patel, Gerry S. M. Rivera, Lisa S. Mydy, Andrew M. Gulick, Timothy A. Wencewicz

Summary: Siderophores are metabolites used by microbes to sequester environmental iron. Streptomyces strains produce desferrioxamine (DFO) siderophores, which consist of repeating units of hydroxamate-based desferrioxamine and succinate. In this study, we characterized four DesD orthologs from Streptomyces strains that produce unique DFO siderophores. We synthesized a structural mimic of N-1-hydroxy-N-1-succinyl-cadaverine and obtained crystal structures of DesD in different forms. Our findings suggest that acyl-AMS derivatives can be useful tools to study the mechanism and structure of this family of enzymes.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Neurosciences

Downregulation of Ubiquitin-Specific Protease 15 (USP15) Does Not Provide Therapeutic Benefit in Experimental Mesial Temporal Lobe Epilepsy

Ute Haeussler, Joao Neres, Catherine Vandenplas, Caroline Eykens, Irena Kadiu, Carolin Schramm, Renaud Fleurance, Phil Stanley, Patrice Godard, Laurane de Mot, Jonathan van Eyll, Klaus-Peter Knobeloch, Carola A. Haas, Stefanie Dedeurwaerdere

Summary: Structural epilepsies display complex immune activation signatures, but the specific neuroinflammatory pathways driving the pathology are unclear. Transcriptome studies in patients with mesial temporal lobe epilepsy (mTLE) identified dysregulation of transforming growth factor beta, interferon alpha/beta, and nuclear factor erythroid 2-related factor 2 pathways. However, in a mouse model, lack of Usp15 did not significantly affect severity of status epilepticus or the expression of inflammatory pathways.

MOLECULAR NEUROBIOLOGY (2023)

Review Biochemistry & Molecular Biology

Structural advances toward understanding the catalytic activity and conformational dynamics of modular nonribosomal peptide synthetases

Ketan D. Patel, Monica R. MacDonald, Syed Fardin Ahmed, Jitendra Singh, Andrew M. Gulick

Summary: Nonribosomal peptide synthetases (NRPSs) are enzymes that catalyze the biosynthesis of important peptide natural products. The NRPS architecture involves an assembly line strategy that tethers amino acid building blocks and growing peptides. While conserved conformational states have been identified within a single module, interactions between modules are more dynamic. This article describes the structures of NRPS protein domains and modules and discusses their implications for future natural product discovery.

NATURAL PRODUCT REPORTS (2023)

No Data Available